Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to hyperparathyroidism: hypoparathyroidism, Primary hyperparathyroidism, Secondary hyperparathyroidism


(ˌhaɪ pərˌpær əˈθaɪ rɔɪˌdɪz əm)

overactivity of the parathyroid gland, characterized by muscular weakness and softening of the bones.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hyperparathyroidism - excessive secretion of parathyroid hormone resulting in abnormally high levels of calcium in the blood; can affect many systems of the body (especially causing bone resorption and osteoporosis)
adenosis, gland disease, glandular disease, glandular disorder - a disorder of the glands of the body
hypoparathyroidism - inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood


n hiperparatiroidismo
References in periodicals archive ?
Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism.
Primary hyperparathyroidism is characterized by inappropriately elevated iPTH in presence of hypercalcaemia and both these may alter the functional status of hypothalmo-pituitary-adrenocortical (HPA) axis in these patients.
At this point, a diagnosis of primary hyperparathyroidism was considered and localization studies were ordered to find the parathyroid adenoma.
The company has an advanced portfolio of new products targeting vitamin D deficiency and secondary hyperparathyroidism in patients with moderate to severe chronic kidney disease and end stage renal disease.
Cinacalcet HCl is a new calcimimetic agent that has been used successfully for the treatment of primary and secondary hyperparathyroidism in adults (10-12), but its use in adolescents with persistent primary hyperparathyroidism has not been previously reported.
Sensipar: The metabolic disease drug has been approved to treat various parathyroid disorders and is in two trials to treat hyperparathyroidism.
Hypercalcemia might be associated with hyperthyroidism alone or may occur as a manifestation of associated primary hyperparathyroidism, although neither disorder has been hitherto adequately understood.
AFI: Hyperparathyroidism happens when one or more of your parathyroid glands located in your neck start secreting too much parathyroid hormone.
Bone Care International is a pharmaceutical company which is developing vitamin D-hormone therapies with improved safety and efficacy profiles for treatment of a) secondary hyperparathyroidism associated with end-stage renal disease and pre-dialysis renal disease, b) osteoporosis, c) psoriasis, and d) cancers of the breast, prostate, and colon.
It is sometimes difficult to decide whether hyperparathyroidism in FMEN1 is severe enough to need treatment, especially in a person who has no symptoms.
According to the report, the hyperparathyroidism patient population is expected to increase over future years, primarily due to increasing Chronic Kidney Disease (CKD) prevalence and an increase in the elderly population.
Contract award: tlzp / 2-23 / 233/16/2015 purchase and delivery of a medicament for the treatment of secondary hyperparathyroidism.